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RHOB promoter polymorphisms cooperate in regulating RHOB
transcriptional activity and thus chondrocyte apoptosis whereby
an increase in chondrocyte apoptosis is predicted to result in the
net loss of articular cartilage.
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Purpose: Chondrogenic differentiation by mesenchymal stem
cells (MSCs) is associated with cytokines such as transforming
growth factor-β (TGF-β). This investigation was conducted to
examine the gene expression of the three isoforms of TGF-β
(1,2,3) and their receptors (TBR-I, TBR-II, TBR-III) in primary
MSCs culture established from bone marrow from patients with
end-stage osteoarthritis (OA).
Methods: MSCs were prepared from bone marrow aspirates
obtained from 18 patients undergoing joint replacement as a
result of OA and from 10 healthy donors. Total RNA was ex-
tracted from primary MSCs culture established from these cells
and quantitative real time reverse-transcription-polymerase chain
reaction was performed. Specific primers sequences of TGF-β
isoforms and their receptors, and rRNA18S, as internal control,
were used in this study. Shapiro-Wilk test was used to study the
normality of variables. Data are reported either as normalization
ratio (NR) mean ± SD in normal conditions or as NR median and
percentiles (percentile 25-percentile 75) if the variables did not fit
a Gaussian distribution. Normal variables were compared using
Student’s t test and non-normal variables using Mann-Whitney U
tests. P values less than 0.05 were considered significant.
Results: Compared to controls, total TGF-β mRNA expression
significantly increased in MSCs from OA patients. In relation to
TGF-β isoforms, only TGF-β1 showed a significant increase on
the expression in MSCs. TBR-I showed no significant change
between groups; however, both TBR-II and TBR-III increased
significantly in MSCs from OA patients compared with controls.
Data are summarized in table:
Gene expression of TGF-β, isoforms and receptors, in MSCs of OA patients
Gene NR OA patients NR controls p
TGF-β 0.61±0.28 0.40±0.24 0.042
TGF-β1 2.07±0.99 1.20±1.05 0.036
TGF-β2 2.25 [0.78-5.34] 2.94 [0.78-6.44] 0.982
TGF-β3 18.13 [11.20-27.29] 14.54 [0.35-25.5] 0.734
TBR-I 0.17 [0.05-0.76] 0.11 [0.06-0.31] 0.441
TBR-II 0.17 [0.08-0.26] 0.05 [0.02-0.06] 0.001
TBR-III 0.18 [0.07-1.38] 0.06 [0.03-0.35] 0.021
Conclusions: These results indicate that primary MSCs culture
established from patients with OA show an up-regulation on the
expression of total TGF-β, isoform TGF-β1, TBR-II and TBR-III
receptors. This response may be at the basis of inefficient wound
repair in cartilage in OA. Further studies should address the
possible involvement of the TGF-β1/TBRII and TBR-III system in
the pathophysiology of OA.
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Purpose: To confirm previous studies showing association of friz-
zled related protein 3 (FRZB) non-synonymous polymorphisms
with hip OA in women or with generalized OA, and to explore
possible involvement in other OA phenotypes.
Methods: A case-control study was done with three groups of
Spanish OA patients: patients that had undergone total joint
replacement for primary OA in the hip, THR (n = 310), or the
knee, TKR (n = 277) and patients with hand OA according to
the ACR classification criteria, HOA (n = 242). All patients were
specifically questioned and explored and their clinical records
were reviewed regarding the involvement of other joint regions.
Controls were more than 55 years old and were selected because
they did not show clinical OA symptoms (n = 294). SNPs resulting
in R200W (rs288326) and in R324G (rs7775) substitutions in
exons 4 and 6 of FRZB, respectively, were genotyped with
fluorogenic 5’ nuclease assays (TaqMan, AppliedBiosystems).
Results: There were not significant differences in allele frequen-
cies of any of the two SNPs between controls and each of the
three groups of OA patients. These results were not modified
by stratifying according to sex, or by pooling all OA patients in
a single group, or by considering genotypes at the two SNPs
jointly. However, allele G of the R324G SNP showed a trend
to higher frequency in patients with OA at multiple joints (p =
0.07). This trend was restricted to female patients (p = 0.10) and
more specifically to the subgroup of women in the THR group
(8.3% in patients without other affected joints versus 16.2% in
patients with them, p = 0.04). The increase in G allele frequency
was more marked in those patients showing a larger number of
OA affected joint regions (13.1% with one, 15.9% with two and
24.1% with more than two additionally affected joints, p = 0.006
for the trend).
Conclusions: These results add further evidence indicating that
the non-synonymous SNP in exon 6 of the FRZB gene play a role
in the development of OA. They suggest a subphenotype where
the effect could be clearer: female patients with polyarticular OA
and severe involvement of the hip joint. If this subphenotype
is confirmed with additional studies it will be compatible with
previous results that have found either association with hip OA
in females or with generalized OA in both sexes.
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Purpose: Osteoarthritic chondrocytes produce multiple cy-
clooxygenase and lipoxygenase products, predominantly
prostaglandin (PG) E2, which in turn affect chondrocyte phe-
notype. We report here the effects of PGE2 on the expres-
sion/activity of NURR1, an immediate early gene and member of
the nuclear receptor superfamily.
